As a science-focused biotechnology company, Senescence Life Sciences is applying our research to a variety of thereapies across three businesses:
Off-the-shelf, market-ready range of nutraceutical products to improve brain health, and increase cognitive performance.
- Focus on purity, consistency and safety.
- Full white label services for select brands and countries.
- Multiple formats available.
- Robust, ongoing clinical research to support marketing and regulatory team.
A novel formulation designed to improve reaction time, focus, spatial awareness, and combat decision fatigue experienced by athletes, eSports professionals and other neuro-intensive activities.
- Drink formulation currently undergoing development, with expected first clinical trial in early 2020.
- Developed by SLS Performance and world’s leading flavour company.
- Designed as an alternative to current high sugar, high caffeine energy drinks.
Pharmaceutical division focusing on developing next-generation, clinically tested medicines for the prevention and treatment of Alzheimer’s disease.
- Drug pipeline includes a multi-therapeutic targeting cellular repair cycles upstream of β-Amyloid production.
- Currently in pre-clinical, with first in-human trials slated for end 2020.
SUPPORTING MARKET SUCCESS
Senescence also provides partners with support in the following areas.
Thoght leadership through
available neuroscience experts
Development of clinical claims
and clinical trials support for new
aspects of cognitive improvement